March 3, 2023 — iRhythm Technologies, Inc. , a leading digital health company focused on creating trusted solutions that ...
March 3, 2023 — Researchers may be able to predict cardiovascular disease – such as atrial fibrillation and heart ...
March 3, 2023 —CathWorks announced key events for the company during the annual American College of Cardiology (ACC) ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 3, 2023 — Experiencing lasting symptoms months after catching COVID-19, known as long COVID, was found to more ...
March 2, 2023 — ReCor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced that primary ...
March 2, 2023 — Royal Philips is showcasing enhancements to its cardiology portfolio at the Annual Scientific Session & ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being ...
March 1, 2023 — Mesoblast Limited, global leader in allogeneic cellular medicines for inflammatory diseases, today ...
March 1, 2023 — SpectraWAVE, Inc., a medical imaging company focused on improving the treatment and outcomes for ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
March 1, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), using a ...
February 28, 2023 — Eko, a digital health company applying artificial intelligence (AI) in the fight against heart and ...
February 28, 2023 — Experts from the Smidt Heart Institute at Cedars-Sinai, California’s premier cardiology and heart ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
February 28, 2023 — On Feb. 27, the U.S. Food and Drug Administration (FDA) issued a Letter to Health Care Providers to ...
February 27, 2023 — Conformal Medical, Inc. announced today the results from the CONFORMAL Early Feasibility Study (EFS) ...
February 27, 2023 — Amarin Corporation plc announced that data evaluating the role of VASCEPA /VAZKEPA (icosapent ethyl) ...